Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay A Fishman

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Clinical Microbiology Reviews|January 31, 2025
Surveillance and prevention of infection in clinical xenotransplantationAdam G Stewart, Jay A Fishman
Nature Reviews. Nephrology|September 3, 2014
Donor-derived infection--the challenge for transplant safetyJay A Fishman, Paolo A Grossi
Journal of the American Society of Nephrology : JASN|April 15, 2005
Viral infection in the renal transplant recipientCamille N Kotton, Jay A Fishman
Emerging Infectious Diseases|June 25, 2024
Infectious Diseases and Clinical XenotransplantationJay A Fishman, Nicolas J Mueller
The New England Journal of Medicine|May 20, 2011
Alemtuzumab in kidney-transplant recipientsJames F Markmann, Jay A Fishman
Transplantation|November 11, 2010
Screening of deceased organ donors: no easy answersRobert C Huang, Jay A Fishman
Journal of Hepatology|August 22, 2006
How should we evaluate organ donors with active or prior infections?Nicolas J Mueller, Jay A Fishman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2020
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression"Matthew B Roberts, Jay A Fishman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2014
Reply to Antinori et alAlissa J Wright, Jay A Fishman
Clinics in Chest Medicine|November 3, 2005
Cytomegalovirus pneumonia in transplant recipientsMichael G Ison, Jay A Fishman
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Clinical Microbiology Reviews|January 31, 2025
Surveillance and prevention of infection in clinical xenotransplantationAdam G Stewart, Jay A Fishman
Nature Reviews. Nephrology|September 3, 2014
Donor-derived infection--the challenge for transplant safetyJay A Fishman, Paolo A Grossi
Journal of the American Society of Nephrology : JASN|April 15, 2005
Viral infection in the renal transplant recipientCamille N Kotton, Jay A Fishman
Emerging Infectious Diseases|June 25, 2024
Infectious Diseases and Clinical XenotransplantationJay A Fishman, Nicolas J Mueller
The New England Journal of Medicine|May 20, 2011
Alemtuzumab in kidney-transplant recipientsJames F Markmann, Jay A Fishman
Transplantation|November 11, 2010
Screening of deceased organ donors: no easy answersRobert C Huang, Jay A Fishman
Journal of Hepatology|August 22, 2006
How should we evaluate organ donors with active or prior infections?Nicolas J Mueller, Jay A Fishman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2020
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression"Matthew B Roberts, Jay A Fishman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2014
Reply to Antinori et alAlissa J Wright, Jay A Fishman
Clinics in Chest Medicine|November 3, 2005
Cytomegalovirus pneumonia in transplant recipientsMichael G Ison, Jay A Fishman
Pageof 15